Today we are delighted to introduce Tine Iskov Kopp who recently joined our Danish team as Senior Lead Analyst.
Tine has a PhD in molecular epidemiology and extensive experience with designing and […]
Today we are thrilled to introduce Mary (Ellie) Dillon who recently joined our team in Stockholm as Lead Analyst!
Ellie is currently finishing her PhD at Aalto University Business School, Finland, […]
Quantify’s Alexander Rieem Dun and Jonas Banefelt are co-authors on a recent publication on the effects of intensity and adherence to lipid-lowering treatment on the risk of cardiovascular events in patients with […]
We are excited to introduce our new Director Dr. Béranger Lueza who joined our international Modelling, Access and Strategy unit this week. Béranger is based in Stockholm and has more […]
Do you want to know more about the evidence behind pediatric pneumococcal conjugate vaccine (PCV) recommendations in Europe? Linked below is a recent publication, co-authored by Quantify’s Hanna Fues Wahl, that summarizes the findings from a systematic literature review of pediatric […]
Earlier this week the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) based primarily on real-world evidence (RWE). The decision reflects the increasing importance of real-world data (RWD) […]
Are you attending the 10th annual national conference of the Swedish Health Economics Association (SHEA) in Gothenburg this week? In that case we really hope that you were able to listen in on Quantify’s Douglas Knutsson yesterday when he presented an excerpt […]
Today we are happy to introduce Philip Gavuzzi who joined the Stockholm team as a Research Analyst last week. Philip has a background in economic analysis and hold […]
Today we are delighted to introduce Ethan O’Leary who joined our Stockholm team as a Research Analyst this Monday!
Ethan is currently finishing his Master’s in Economics from Stockholm School […]